Form 4: Insider Sells Shares to Cover Tax Withholding

Tiffany Inglis, Chief Medical Officer of Sera Prognostics, Inc., sold 362 shares of Class A Common Stock to cover tax withholding obligations related to vested restricted stock units.

Summary

• Tiffany Inglis, Chief Medical Officer at Sera Prognostics, Inc. (SERA), reported a transaction on June 11, 2026.
• She sold 362 shares of Class A Common Stock.
• The sale was executed at a weighted average price of $2.01 per share, with individual transactions ranging from $1.87 to $2.12.
• These shares were sold to cover tax withholding obligations arising from the vesting of restricted stock units (RSUs).
• This sale was mandated by the company's policy to satisfy tax withholding through 'sell to cover' transactions and was not a discretionary sale by Ms. Inglis.
• Following this transaction, Ms. Inglis beneficially owns 92,075 shares of Class A Common Stock.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing. The transaction is a routine 'sell to cover' for tax purposes, not a discretionary sale, and the executive retains significant ownership.

Positives

• The sale was a mandatory 'sell to cover' transaction to satisfy tax obligations, not a discretionary sale, indicating no negative sentiment from the executive regarding the company's stock.
• Ms. Inglis retains a significant beneficial ownership of 92,075 shares, suggesting continued commitment to the company.

Negatives

• A total of 362 shares were sold, reducing the reporting person's direct holdings.

Future Outlook

No specific future outlook or guidance is provided in this Form 4 filing, as it solely reports a past transaction.

Industry Context

StockSavvy.ai notes that insider 'sell to cover' transactions are common for executives upon the vesting of equity awards to manage tax liabilities. This type of transaction is generally viewed as routine and not indicative of a lack of confidence in the company's future prospects, especially when the executive retains a substantial number of shares.

Stakeholder Impact

• Shareholders: The sale of 362 shares is unlikely to have a significant impact on the stock price due to its small size and routine nature. The continued substantial ownership by Ms. Inglis may provide some reassurance.

Key Dates

Keywords

Form 4, Insider Transaction, Sera Prognostics, SERA, Stock Sale, Tax Withholding, Restricted Stock Units, RSU Vesting, Chief Medical Officer, Beneficial Ownership